Antibodies and Antibody RNase Fusion Proteins Targeting CD30+ Lymphoma

3,096 views

|

January 5, 2012

  • Share
  • CD30 specific recombinant human antibodies and immunoRNases are produced in high levels using mammalian cell lines. Antibodies as well as immunoRNases mediate inhibitory effects on Hodgkin lymphoma cell lines but immunoRNases show higher efficacy.

    BiopharmaImmunology

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.